Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,275.00
-45.00 (-1.94%)
At close: Oct 23, 2026

Sewoon Medical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
66,52963,65760,15168,24760,11662,579
Revenue Growth
10.39%5.83%-11.86%13.53%-3.94%-1.80%
Gross Profit
25,23723,54522,18827,55722,22025,057
Operating Income
14,33212,70111,37716,92012,18715,386
Net Income
13,89711,91212,16314,95710,40612,282
Earnings Per Share
329.21278.50280.95345.50240.38283.70
EPS Growth
40.63%-0.87%-18.68%43.73%-15.27%17.02%

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
South Korea
48,12746,46344,19749,22245,58047,614
China
3,0772,8723,0583,2943,0982,647
Asia
2,0101,9512,0761,9501,8211,740
Japan
5,3075,5944,3637,0104,3664,668
Europe
4,9933,9474,8075,0584,1354,699
Other
3,0142,8301,6491,7131,1161,211
Total
66,52963,65760,15168,24760,11662,579

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
99,64097,02486,09875,71057,00351,852
Total Debt
1,126763.81,053781.661,043810.09
Net Cash (Debt)
98,51496,26085,04574,92955,96151,042
Net Cash Growth
11.21%13.19%13.50%33.89%9.64%51.57%
Net Cash Per Share
2333.622250.531964.491730.811292.661179.04

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
15,92517,77313,18623,0769,27921,469
Capital Expenditures
-1,630-1,691-1,435-1,949-2,151-2,224
Free Cash Flow
14,29516,08311,75021,1277,12819,244
Free Cash Flow Growth
11.71%36.87%-44.38%196.41%-62.96%13.35%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
37.93%36.99%36.89%40.38%36.96%40.04%
Operating Margin
21.54%19.95%18.91%24.79%20.27%24.59%
Pretax Margin
27.01%23.41%25.97%28.28%22.67%26.57%
Profit Margin
20.89%18.71%20.22%21.92%17.31%19.63%
FCF Margin
21.49%25.26%19.54%30.96%11.86%30.75%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
70.00070.00060.00070.00060.00050.000
Dividend Per Share Growth
16.67%16.67%-14.29%16.67%20.00%0%
Dividend Yield
3.08%2.80%2.43%2.45%2.05%1.20%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
6.918.858.778.2812.1514.65
Forward PE
-13.0913.0913.0913.0913.09
P/FCF Ratio
6.716.559.085.8617.749.35
PS Ratio
1.441.661.771.812.102.87